Skip to main content
. 2019 Dec 15;105(5):e2050–e2060. doi: 10.1210/clinem/dgz262

Figure 2.

Figure 2.

Baroreflex sensitivity (A) and total peripheral resistance (B), at baseline and across postrandomization months 6 and 12, by treatment. Caption: Adjusting for prerandomization levels, a significant main effect of treatment was found for both outcomes (P < 0.05) such that women assigned to TE + IMP had significantly higher baroreflex sensitivity (P = 0.01) and lower total peripheral resistance (P < 0.01) across all stress testing phases compared with women on placebo.